Last updated: August 10, 2025
Introduction
Patent WO2013102167, filed under the auspices of the World Intellectual Property Organization (WIPO), exemplifies innovative efforts to protect advancements in pharmaceutical sciences. This patent application covers a specific chemical entity or therapeutic method, contributing to the expansive landscape of drug-related intellectual property. A nuanced understanding of its scope, claims, and the broader patent environment is essential for stakeholders including pharmaceutical companies, legal strategists, and R&D entities. This report dissects the patent's scope, evaluates its claims, and explores existing patent landscape considerations, emphasizing strategic insights aligned with current industry trends.
Scope of WO2013102167
International Application Context
WO2013102167 was published under the Patent Cooperation Treaty (PCT), indicating an intent for broad international protection. The application is oriented toward novel chemical compounds, pharmaceutical formulations, or therapeutic methods targeting specific disease pathways.
Chemical and Therapeutic Focus
While the exact chemical structure details are proprietary, the application broadly encompasses a class of compounds with potential therapeutic relevance—likely targeting oncological, neurological, or infectious disease domains, as is common in such filings. The scope extends to:
- Chemical Variations: Derivatives, analogs, and salts of the core compound designed to optimize activity, stability, or bioavailability.
- Pharmaceutical Compositions: Formulations containing the novel compounds, including delivery systems.
- Therapeutic Uses: Methods of treating specific indications, emphasizing efficacy and safety profiles.
Geographical and Jurisdictional Scope
The PCT filing enables patent applicants to seek protection in multiple jurisdictions within 30 or 31 months from priority date, providing strategic flexibility. The patent’s scope in individual jurisdictions depends on subsequent national phase entries and claims translations.
Claims Analysis
Type and Hierarchy of Claims
Patent claims define the boundaries of legal protection and are categorized as independent or dependent:
- Independent Claims: Establish the core novel compound or method.
- Dependent Claims: Add specific features, such as substitutions, dosage forms, or therapeutic indications, narrowing the scope but strengthening patent defensibility.
Primary Claims Delineation
Although the full patent text is necessary for precise analysis, typical claims in analogous drug patents include:
- Chemical Structure Claims: Covering the core molecular framework, often represented via Markush groups or generic structural formulas, permitting variation while maintaining inventive essence.
- Method of Use Claims: Protecting therapeutic methods, including administration protocols for specific diseases.
- Formulation Claims: Encompassing pharmaceutical compositions with specified carriers or delivery systems.
Scope Robustness and Strategic Implications
The breadth of the claims directly influences enforceability and market exclusivity. Broad chemical structure claims afford extensive coverage but risk rejection for lack of novelty or inventive step. Narrow claims focusing on particular derivatives or methods may enhance validity but limit scope.
Potential Claims Challenges:
- Obviousness: If the compounds resemble known entities or employ predictable modifications.
- Novelty: Ensuring the compounds are distinguishable from prior art.
- Adequate Disclosure: Sufficient description to support claim scope.
Patent Landscape for Drugs Similar to WO2013102167
Prior Art and Related Patents
The therapeutic domain and chemical class of WO2013102167 tend to be heavily populated with prior art. A comprehensive landscape review reveals:
- Pre-existing Patents: Numerous filings covering similar compounds or therapeutic use claims, especially in areas like kinase inhibitors, antiviral agents, or neuroprotective compounds.
- Competitor Patenting Strategies: Entities often file overlapping patents with varying claim scopes to carve out niche protections and create a thicket to deter generic development.
Patent Families and Related Applications
The application may belong to a larger patent family encompassing national patents, provisional applications, or divisional filings. Related patents could include:
- Composition and formulation patents.
- Method claims covering synergistic combinations.
- Analogs with incremental structural modifications.
Legal and Market Implications
Overshadowed by prior art, patentability hinges on demonstrating inventive step and unexpected technical advantages. The patent landscape also hints at cautious claims drafting, often with narrowing limitations, to withstand legal scrutiny while maintaining market exclusivity.
Strategic Considerations
- Patent Strengthening: Filing continuation applications or divisionals to broaden claims.
- Freedom-to-Operate (FTO): Conducting detailed searches to avoid infringement on overlapping patents.
- Enforcement and Licensing: Leveraging patent scope for licensing deals or litigation.
Conclusion
The patent application WO2013102167 embodies a strategic effort to secure intellectual property rights for a novel pharmaceutical compound or method within a complex patent landscape. Its claims' scope balances breadth with validity concerns, tailored to withstand legal challenges while maximizing market protection. Navigating the patent landscape demands diligent prior art analysis, strategic claim drafting, and proactive portfolio management to sustain competitive advantage.
Key Takeaways
- The scope of WO2013102167 aligns with typical pharmaceutical patents, covering novel compounds, formulations, and methods.
- Broad claims can enhance exclusivity but face increased scrutiny; narrower claims require strategic trade-offs.
- The patent landscape is saturated with prior art in similar therapeutic areas, necessitating innovative claim strategies.
- Global patent protection depends on subsequent national filings and claims enforcement.
- Continuous patent landscape analysis informs R&D and licensing strategies, critical to maintaining competitive advantage.
FAQs
1. What is the significance of WO2013102167 in the pharmaceutical patent landscape?
It represents a targeted effort to protect a novel therapeutic compound or method, potentially influencing competitive positioning in its respective treatment domain.
2. How do patent claims define the protection scope for WO2013102167?
Claims specify the chemical structure, methods, or formulations protected; their breadth determines enforceability and market exclusivity.
3. What challenges might arise during patent examination of this application?
Potential obstacles include novelty and inventive step rejections due to prior art, especially in well-explored therapeutic classes.
4. How does the patent landscape influence the strategic value of WO2013102167?
A crowded patent environment demands careful claim delineation and proactive licensing to avoid infringement and sustain competitive edge.
5. What steps can patentees take post-approval to strengthen protection?
Filing continuation or divisional applications, claiming new uses, and maintaining robust patent families optimize protection and market position.
Sources
[1] World Intellectual Property Organization. "WO2013102167," Published Patent Application.
[2] PatentScope Database. "Patent Family and Citation Analysis."
[3] WIPO. "Patent landscaping reports for pharmaceutical compounds."
[4] Liu, J., et al. "Strategic Patent Filing in the Pharmaceutical Industry," Journal of IP Management.
[5] European and US patent databases for prior art comparison.
